Sound Income Strategies LLC Buys New Position in Danaher Corporation $DHR

Sound Income Strategies LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR) in the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 6,051 shares of the conglomerate’s stock, valued at approximately $1,341,000.

A number of other institutional investors and hedge funds have also bought and sold shares of DHR. Main Street Group LTD purchased a new position in Danaher during the 1st quarter worth $25,000. N.E.W. Advisory Services LLC purchased a new stake in shares of Danaher in the second quarter valued at about $25,000. Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares during the last quarter. Evolution Wealth Management Inc. lifted its position in shares of Danaher by 208.0% during the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 104 shares in the last quarter. Finally, Field & Main Bank bought a new position in shares of Danaher during the second quarter valued at about $29,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Up 1.2%

DHR opened at $220.15 on Friday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company’s 50-day moving average price is $211.38 and its two-hundred day moving average price is $194.62. The stock has a market cap of $154.76 billion, a price-to-earnings ratio of 39.10, a PEG ratio of 2.71 and a beta of 0.76. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.77 EPS. As a group, equities analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is currently 28.42%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on DHR shares. The Goldman Sachs Group upped their price objective on shares of Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Barclays boosted their target price on Danaher from $230.00 to $255.00 and gave the stock an “overweight” rating in a research note on Wednesday. TD Cowen reduced their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Royal Bank Of Canada increased their price target on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday. Finally, UBS Group began coverage on Danaher in a report on Wednesday, September 9th. They set a “buy” rating and a $250.00 price target on the stock. Two research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $235.23.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.